193 related articles for article (PubMed ID: 27764811)
1. Altered RECQL5 expression in urothelial bladder carcinoma increases cellular proliferation and makes RECQL5 helicase activity a novel target for chemotherapy.
Patterson K; Arya L; Bottomley S; Morgan S; Cox A; Catto J; Bryant HE
Oncotarget; 2016 Nov; 7(46):76140-76150. PubMed ID: 27764811
[TBL] [Abstract][Full Text] [Related]
2. Decreased RECQL5 correlated with disease progression of osteosarcoma.
Wu J; Zhi L; Dai X; Cai Q; Ma W
Biochem Biophys Res Commun; 2015 Nov; 467(4):617-22. PubMed ID: 26499077
[TBL] [Abstract][Full Text] [Related]
3. RECQL5/Recql5 helicase regulates homologous recombination and suppresses tumor formation via disruption of Rad51 presynaptic filaments.
Hu Y; Raynard S; Sehorn MG; Lu X; Bussen W; Zheng L; Stark JM; Barnes EL; Chi P; Janscak P; Jasin M; Vogel H; Sung P; Luo G
Genes Dev; 2007 Dec; 21(23):3073-84. PubMed ID: 18003859
[TBL] [Abstract][Full Text] [Related]
4. Human RECQL5: guarding the crossroads of DNA replication and transcription and providing backup capability.
Popuri V; Tadokoro T; Croteau DL; Bohr VA
Crit Rev Biochem Mol Biol; 2013; 48(3):289-99. PubMed ID: 23627586
[TBL] [Abstract][Full Text] [Related]
5. Human RECQ Helicase Pathogenic Variants, Population Variation and "Missing" Diseases.
Fu W; Ligabue A; Rogers KJ; Akey JM; Monnat RJ
Hum Mutat; 2017 Feb; 38(2):193-203. PubMed ID: 27859906
[TBL] [Abstract][Full Text] [Related]
6. DNMT1: an emerging target in the treatment of invasive urinary bladder cancer.
Dhawan D; Ramos-Vara JA; Hahn NM; Waddell J; Olbricht GR; Zheng R; Stewart JC; Knapp DW
Urol Oncol; 2013 Nov; 31(8):1761-9. PubMed ID: 22609058
[TBL] [Abstract][Full Text] [Related]
7. Inducing cell proliferation inhibition and apoptosis via silencing Dicer, Drosha, and Exportin 5 in urothelial carcinoma of the bladder.
Han Y; Liu Y; Gui Y; Cai Z
J Surg Oncol; 2013 Feb; 107(2):201-5. PubMed ID: 22766726
[TBL] [Abstract][Full Text] [Related]
8. RECQL4 in genomic instability and aging.
Croteau DL; Singh DK; Hoh Ferrarelli L; Lu H; Bohr VA
Trends Genet; 2012 Dec; 28(12):624-31. PubMed ID: 22940096
[TBL] [Abstract][Full Text] [Related]
9. Targeting RECQL5 Functions, by a Small Molecule, Selectively Kills Breast Cancer
Chakraborty S; Dutta K; Gupta P; Das A; Das A; Ghosh SK; Patro BS
J Med Chem; 2021 Feb; 64(3):1524-1544. PubMed ID: 33529023
[TBL] [Abstract][Full Text] [Related]
10. RECQL5 plays an essential role in maintaining genome stability and viability of triple-negative breast cancer cells.
Peng J; Tang L; Cai M; Chen H; Wong J; Zhang P
Cancer Med; 2019 Aug; 8(10):4743-4752. PubMed ID: 31231988
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of caldesmon is associated with tumor progression in patients with primary non-muscle-invasive bladder cancer.
Lee MS; Lee J; Kim JH; Kim WT; Kim WJ; Ahn H; Park J
Oncotarget; 2015 Nov; 6(37):40370-84. PubMed ID: 26430961
[TBL] [Abstract][Full Text] [Related]
12. Insights into the RecQ helicase mechanism revealed by the structure of the helicase domain of human RECQL5.
Newman JA; Aitkenhead H; Savitsky P; Gileadi O
Nucleic Acids Res; 2017 Apr; 45(7):4231-4243. PubMed ID: 28100692
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of thymosin β4 in the regulation of epithelial-mesenchymal transformation in urothelial carcinoma.
Wang ZY; Zeng FQ; Zhu ZH; Jiang GS; Lv L; Wan F; Dong R; Xiao XY; Xing SA
Urol Oncol; 2012; 30(2):167-76. PubMed ID: 20864366
[TBL] [Abstract][Full Text] [Related]
14. Transient receptor potential vanilloid type 2 (TRPV2) expression in normal urothelium and in urothelial carcinoma of human bladder: correlation with the pathologic stage.
Caprodossi S; Lucciarini R; Amantini C; Nabissi M; Canesin G; Ballarini P; Di Spilimbergo A; Cardarelli MA; Servi L; Mammana G; Santoni G
Eur Urol; 2008 Sep; 54(3):612-20. PubMed ID: 17977643
[TBL] [Abstract][Full Text] [Related]
15. A Blm-Recql5 partnership in replication stress response.
Lu X; Lou H; Luo G
J Mol Cell Biol; 2011 Feb; 3(1):31-8. PubMed ID: 21278449
[TBL] [Abstract][Full Text] [Related]
16. Direct inhibition of RNA polymerase II transcription by RECQL5.
Aygün O; Xu X; Liu Y; Takahashi H; Kong SE; Conaway RC; Conaway JW; Svejstrup JQ
J Biol Chem; 2009 Aug; 284(35):23197-203. PubMed ID: 19570979
[TBL] [Abstract][Full Text] [Related]
17. Notch3 overexpression enhances progression and chemoresistance of urothelial carcinoma.
Zhang H; Liu L; Liu C; Pan J; Lu G; Zhou Z; Chen Z; Qian C
Oncotarget; 2017 May; 8(21):34362-34373. PubMed ID: 28416766
[TBL] [Abstract][Full Text] [Related]
18. Heat-shock protein 70-2 (HSP70-2) expression in bladder urothelial carcinoma is associated with tumour progression and promotes migration and invasion.
Garg M; Kanojia D; Seth A; Kumar R; Gupta A; Surolia A; Suri A
Eur J Cancer; 2010 Jan; 46(1):207-15. PubMed ID: 19914824
[TBL] [Abstract][Full Text] [Related]
19. Mining the role of RECQL5 in gastric cancer and seeking potential regulatory network by bioinformatics analysis.
Lin Y; Chen H; Wang X; Xiang J; Wang H; Peng J
Exp Mol Pathol; 2020 Aug; 115():104477. PubMed ID: 32497619
[TBL] [Abstract][Full Text] [Related]
20. Treatment with low-dose interferon-alpha restores the balance between matrix metalloproteinase-9 and E-cadherin expression in human transitional cell carcinoma of the bladder.
Slaton JW; Karashima T; Perrotte P; Inoue K; Kim SJ; Izawa J; Kedar D; McConkey DJ; Millikan R; Sweeney P; Yoshikawa C; Shuin T; Dinney CP
Clin Cancer Res; 2001 Sep; 7(9):2840-53. PubMed ID: 11555602
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
